🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Status
Completed
Location
National University Hospital
Start Date
2007-05
Trial ID
NCT00717184
Treatments Being Tested
The purpose of this study is to find the number of natural killer (NK) cell...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2018-05-22
Trial ID
NCT02890758
Treatments Being Tested
This is an open-label, multi-center study to evaluate the safety, tolerabil...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2021-11-03
Trial ID
NCT05099549
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
This study is divided into two phases. Patients with recurrent or metastati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-30
Trial ID
NCT06991478
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This is a single arm, open-label, early phase Ⅰ study, to determine the saf...
Status
Unknown
Location
Hunan Provincial People's Hospital
Start Date
2019-03-21
Trial ID
NCT03910842
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Status
Withdrawn
Location
Children's Memorial Hospital
Start Date
2008-09
Trial ID
NCT00874315